obinutuzumab,lenalidomide
roche
['lymsm', 'award', 'dlbcl', 'obinutuzumab']
excellent work by presenting our trial of obinutuzumab + lenalidomide with chop for patients with new dlbcl, supported by a award! #asco22 #lymsm 
Director of Clinical Research, Section Chief of Aggressive Lymphomas @MDAndersonNews, @ASCO Board member & Govt Relations Committee Chair-elect, Opinions mine